Hard Data On Remdesivir, And On Hydroxychloroquine

Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and much more. Our mission is to provide practice-focused clinical and drug information that is reflective of current and emerging principles of care that will assist to inform oncology decisions. Apparently the impact of HC on IL-6 DOES matter… Continue reading Hard Data On Remdesivir, And On Hydroxychloroquine

Hard Data On Remdesivir, And On Hydroxychloroquine

You can view that these were indeed at-risk patients – the overall mortality rate in the overall population for coronavirus infections is nowhere near those rates, and it’s a damn good thing it isn’t. The mean age of the patients was 59 years, 64% male, with 50% of these having hypertension, 45% of them obese,… Continue reading Hard Data On Remdesivir, And On Hydroxychloroquine